Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Day One Biopharmaceuticals (DAWN) Income from Non-Controlling Interests (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Income from Non-Controlling Interests for 4 consecutive years, with $19.7 million as the latest value for Q3 2025.

  • For Q3 2025, Income from Non-Controlling Interests rose 154.56% year-over-year to $19.7 million; the TTM value through Sep 2025 reached $145.3 million, up 73.74%, while the annual FY2024 figure was $88.4 million, 53.23% down from the prior year.
  • Income from Non-Controlling Interests was $19.7 million for Q3 2025 at Day One Biopharmaceuticals, down from $30.3 million in the prior quarter.
  • The five-year high for Income from Non-Controlling Interests was $142.2 million in Q4 2022, with the low at -$36.2 million in Q3 2024.
  • Historically, Income from Non-Controlling Interests has averaged $42.1 million across 4 years, with a median of $45.9 million in 2023.
  • The largest annual shift saw Income from Non-Controlling Interests tumbled 178.34% in 2024 before it soared 962.07% in 2025.
  • Over 4 years, Income from Non-Controlling Interests stood at $142.2 million in 2022, then plummeted by 61.66% to $54.5 million in 2023, then grew by 8.68% to $59.2 million in 2024, then crashed by 66.7% to $19.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Non-Controlling Interests were $19.7 million in Q3 2025, $30.3 million in Q2 2025, and $36.0 million in Q1 2025.